Joint Statement by independent United Nations human rights experts* on human rights responsibilities of armed non-State actors

Human Rights – Armed Non-State Actors

Joint Statement by independent United Nations human rights experts* on human rights responsibilities of armed non-State actors
GENEVA (25 February 2021) – A group of independent United Nations human rights experts* issued the following joint statement, in order to highlight the far-reaching negative human rights impacts of armed non-State actors1 on rights’ holders and human rights defenders.

In view of the pervasiveness of armed non-State actors’ involvement worldwide – during both armed conflict and other situations of violence – we consider it imperative that existing international legal protections be effectively implemented to safeguard the human rights of individuals and groups, irrespective of the status or character of the perpetrator(s). In accordance with the idea that human rights protection devolves with territory (inalienability of human rights),2 victims must be in a position to seek redress for violations or abuses of their rights regardless of the actor at the origin of their grievance.

Common practice of various organs of the United Nations, such as the Security Council, the General Assembly and the Human Rights Council, contributes to gradual closing of the above-mentioned gap in human rights protection.3 Such practice acknowledges that, at a minimum, armed non-State actors exercising either government-like functions or de facto control over territory and population must respect and protect the human rights of individuals and groups. Some special procedures and investigative mechanisms of the Human Rights Council have argued that armed groups have human rights obligations, for instance derived from their capacities4 , and they have detailed the conditions under which these obligations may apply and their extent5 . Others have expressed concern at abuses of human rights by armed non-State actors, and directly called on these actors to cease such conduct6 , such as the recruitment of child soldiers7 and sexual violence8 . Yet others have noted that the presence of armed non-State actors present unique challenges for business enterprises, which are expected to exercise heightened human rights due diligence in conflict-affected contexts in order to meet the business responsibility to respect human rights in line with the UN Guiding Principles on Business and Human Rights.

However, much remains to be accomplished in order to ensure that human rights of individuals and groups are respected, protected and fulfilled, irrespective of the character of the perpetrator(s). We thus strongly call on States to support initiatives/processes/work on this crucial issue, including processes seeking to identify ways of engaging with armed non-State actors, to strengthen accountability and address impunity.

In particular, we make the following recommendations:
States should:
[1] in any territory under their jurisdiction9 , respect their obligation to monitor and prevent violations of human rights committed by armed non-State actors or violations by armed non-State actors empowered to exercise governmental authority or acting with Government acquiescence;
[1] properly investigate all allegations of human rights violations by armed non-State actors, prosecute and punish perpetrators, and ensure adequate reparation and redress to victims, in full compliance international human rights law and standards;
[1] provide appropriate redress, reparations and other assistance to victims, in cases of both direct and indirect responsibility for abuses committed by armed non-State actors, in particular in cases where armed non-state actors are unable or unwilling to meet their responsibilities in this regard.
[1] contribute to and/or support the clarification and codification of human rights responsibilities of armed non-State actors;
[1] evaluate current mechanisms for holding armed non-State actors accountable and identify approaches to effectively address protection and justice gaps and vacuums;
[1] encourage the adoption by armed non-State actors of policies, practices and codes of conduct for human rights protection;
[1] develop guidelines for human rights-based engagement with armed non-State actors.
[1] adopt a gender-sensitive approach and ensure that these recommendations are implemented taking into account the heightened risk of abuse against women and children, including for sexual and gender-based crimes, and child soldier recruitment;
[1] ensure that the experiences of groups with specific vulnerabilities and individuals within these groups, such as migrants, minorities, LGBTI, older persons and persons with disabilities10 , among others, are fully integrated in the implementation of these recommendations.

Armed non-State actors should:
[1] expressly commit and signify their willingness to respect, protect and fulfil human rights;
[1] implement their human rights responsibilities in their codes of conduct or other internal documents;
[1] ensure proper and genuine accountability within their ranks and organizations for abuses of human rights.

Other stakeholders11 should:
[1] engage directly and concretely with armed non-state actors with the aim to encourage respect for human rights;
[1] if acting as permanent monitoring and reporting mechanisms, ensure that they effectively and transparently assess and report on the compliance of armed non-State actors with human rights;
[1] encourage and support armed non-State actors in adopting and adhering to international human rights standards.

We, United Nations human rights experts, will continue to integrate and recommend the integration of the monitoring and implementation of the human rights responsibilities of armed non-State actors in the exercise of our mandates.

Nothing in this joint statement shall be construed as limiting the human rights obligations of States or as affecting the legal status of armed non-State actors under domestic or international law. Nothing in the present statement shall be understood as calling into question the applicability, and binding character, of rules of international humanitarian law to all parties to armed conflicts – whether they are a State or non-State actor.

.

*This statement has been made jointly by:
Mr. Nils Melzer, Special Rapporteur on Torture and other Cruel, Inhuman or Degrading Treatment or Punishment;
Ms. Agnes Callamard, Special Rapporteur on extrajudicial, summary or arbitrary executions;
Mr. S. Michael Lynk, Special Rapporteur on the Situation of Human Rights in the Palestinian Territory occupied since 1967;
Ms. Isha Dyfan, Independent Expert on the situation of human rights in Somalia;
Mr. David R. Boyd, Special Rapporteur on Human Rights and the Environment
Mr. Tomoya Obokata, Special Rapporteur on contemporary forms of slavery, including its causes and consequences;
Mr. Thomas Andrews, Special Rapporteur on the situation of human rights in Myanmar;
Ms. Mama Fatima Singhateh, Special Rapporteur on the sale and sexual exploitation of children; Mr. Pedro Arrojo Agudo, Special Rapporteur on the human rights to safe drinking water and sanitation;
Ms. Mary Lawlor, Special Rapporteur on the situation of human rights defenders;
Mr. Livingstone Sewanyana, Independent Expert on the promotion of a democratic and equitable international order;
Mr. Michael Fakhri, Special Rapporteur on Right to Food;
Ms. Jelena Aparac (Chair-Rapporteur),
Ms. Lilian Bobea, Mr. Chris Kwaja, Mr. Ravindran Daniel, and Ms. Sorcha MacLeod, Working Group on the use of mercenaries;
Ms. Irene Khan, Special Rapporteur on the promotion and protection of freedom of opinion and expression;
Mr. Javaid Rehman, Special Rapporteur on the situation of human rights in the Islamic Republic of Iran;
Ms. Cecilia Jimenez-Damary, Special Rapporteur on the human rights of internally displaced persons;
Mr. Balakrishnan Rajagopal, Special Rapporteur on adequate housing as a component of the right to an adequate standard of living;
Mr. Dante Pesce (Chair), Mr. Surya Deva (Vice-Chair), Ms. Elżbieta Karska, Mr. Githu Muigai, Ms. Anita Ramasastry, Working Group on human rights and transnational corporations and other business enterprises;
Mr. Gerard Quinn, Special Rapporteur on the rights of persons with disabilities;
Mr. Fernand de Varennes, Special Rapporteur on minority issues;
Ms. Dubravka Simonovic, Special Rapporteur on violence against women, its causes and consequences;
Mr. Ahmed Shaheed, Special Rapporteur on freedom of religion or belief;
Ms. Tlaleng Mofokeng, Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health;
Mr. Diego García-Sayán, Special Rapporteur on the independence of judges and lawyers;
Mr. Clement Nyaletsossi Voule, Special Rapporteur on the right to peaceful assembly and association;
Mr. Felipe González Morales, Special Rapporteur on the human rights of migrants;
Ms. Leigh Toomey (Chair-Rapporteur), Ms. Elina Steinerte (Vice-Chair), Ms. Miriam Estrada-Castillo, Mr. Mumba Malila and Mr. Seong-Phil Hong, Working Group on Arbitrary Detention, and Ms. Elizabeth Broderick (Chair), Ms. Melissa Upreti (Vice Chair), Ms. Dorothy Estrada Tanck, Ms. Ivana Radačić and Ms. Meskerem Geset Techane, Working Group on discrimination against women and girls.

Security Council Calls for Increased Global Cooperation to Facilitate COVID-19 Vaccine Access in Conflict Areas, Unanimously Adopting Resolution 2565 (2021)

COVID Vaccines – UN Security Council; UNESCO

Security Council Calls for Increased Global Cooperation to Facilitate COVID-19 Vaccine Access in Conflict Areas, Unanimously Adopting Resolution 2565 (2021)
26 February 2021
SC/14454
The Security Council today announced the adoption of a resolution calling for strengthened international cooperation to facilitate equitable and affordable access to COVID-19 vaccines in armed conflict and post-conflict situations, and during complex humanitarian emergencies.

Acting through its special silence procedure enacted during the pandemic, the Council unanimously adopted resolution 2565 (2021), recognizing the role of extensive immunization against COVID-19 as a global public good for health. It stressed the need to develop international partnerships, particularly to scale-up manufacturing and distribution capabilities, in recognition of differing national contexts.

By other terms, it reiterated its demand for a general and immediate cessation of hostilities in all situations on its agenda, demanding as well that all parties to armed conflicts engage immediately in a durable, extensive, and sustained humanitarian pause to facilitate the equitable, safe and unhindered delivery and distribution of COVID-19 vaccinations in areas of armed conflict.

Reaffirming that these calls do not apply to military operations against Islamic State in Iraq and the Levant (ISIL/Da’esh), Al-Qaida and Al-Nusra Front, or their associates, the Council demanded that all parties to armed conflicts fully comply with their obligations under international law.

Further, the Council requested the Secretary-General to provide a full assessment of the impediments to vaccine accessibility and the COVID-19 response, including vaccination programmes, in situations of armed conflict and complex humanitarian emergencies — and as necessary, make recommendations to the Council. It expressed its intention to review situations brought to its attention by the Secretary-General where hostilities and armed group activities are impeding COVID 19 vaccination and to consider what further measures may be necessary to ensure such impediments are removed, and hostilities paused to enable vaccination.

It emphasized the urgent need for “solidarity, equity and efficacy”, inviting donation of vaccine doses from developed economies and all those in a position to do so to low- and middle-income countries and other countries in need, particularly through the COVAX Facility — a global mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

[Security Council resolutions are currently adopted through a written procedure vote under temporary, extraordinary and provisional measures implemented in response to the COVID-19 pandemic, as set out in a letter (document S/2020/253) by its President for March 2020 (China).]

::::::

UNESCO calls for COVID-19 vaccines to be considered a global public good
24/02/2021
UNESCO’s International Bioethics Committee (IBC) and the World Commission on the Ethics of Scientific Knowledge and Technology (COMEST) have called for a change of course in current COVID-19 vaccination strategies, urging that vaccines be treated as a global public good to ensure they are made equitably available in all countries, and not only to those who bid the highest for these vaccines. Both committees have a long track record in providing ethical guidance on sensitive issues*.

The statement was presented during an online event on 24 February, which gathered UNESCO’s ethics bodies together with Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, and Professor Jeffrey Sachs from Columbia University.

The IBC-COMEST Statement stresses three key messages:
Firstly, pharmaceutical industries have a responsibility to share the intellectual property acquired with government support to enable manufacturers in all countries to provide access to vaccines for all, which should be considered a global public good. The IBC and COMEST also stress the responsibility of the pharmaceutical industry to invest in factories capable of producing vaccines of the highest possible efficacy and facilitating rapid distribution where needed.

Secondly, the IBC and COMEST say that the vaccine’s benefit to the greatest number of people cannot be considered the sole ethical criterion. Equality, equity, protection from vulnerability, reciprocity and the best interests of children must also be taken into account. Furthermore, decisions on fair distribution and prioritization should be based on the advice of a multidisciplinary group of experts in bioethics, law, economics, and sociology, together with scientists.

Thirdly, the IBC and COMEST consider that vaccination strategies should be based on a non-compulsory, non-punitive model, grounded in information and education, including dialogue with people who may be hesitant about vaccination or hostile to it. Refusing to be vaccinated should not affect the individual’s fundamental rights, specifically his or her right to access healthcare or employment.

Other issues the statement covers include: international cooperation across all different sectors working on COVID-19 to share the benefits of research; the sustainability issues that favour the emergence of zoonotic diseases; trust in science and healthcare authorities; the indispensable need for dialogue between science, ethics, politics and civil society.

Leading Business and Nonprofit Organizations Launch Health Action Alliance to Strengthen and Accelerate COVID-19 Response

COVID 19 – Integrated Response in U.S.

Leading Business and Nonprofit Organizations Launch Health Action Alliance to Strengthen and Accelerate COVID-19 Response
The Ad Council, Business Roundtable, CDC Foundation, de Beaumont Foundation and Robert Wood Johnson Foundation join forces to empower business community, address health inequities

FEBRUARY 18, 2021 WASHINGTON, DC – The Ad Council, Business Roundtable, the CDC Foundation, the de Beaumont Foundation and the Robert Wood Johnson Foundation today announced the launch of the Health Action Alliance (HAA), a new partnership between leading business, communications and public health organizations to strengthen and accelerate the business community’s response to COVID-19. The Alliance is powered by Meteorite, an impact firm that builds coalitions to improve lives and strengthen communities.

Fortune 500 companies employ more than 28 million people, and small businesses employ nearly 60 million people in the United States. Recent research from Morning Consult shows that 71% of Americans trust their employer to make the right decision about when it’s safe to return to the office. HAA will empower a network of businesses of all shapes and sizes to improve the health of employees and communities by promoting COVID-19 prevention and vaccine education and strengthen public health infrastructure to be better prepared in the future. The Alliance will also work to advance health equity by addressing the needs of disproportionately affected communities.

“The COVID-19 pandemic continues to have devastating impacts on the lives and livelihoods of millions of Americans, but as the historic vaccine rollout gets underway, there is increased reason for optimism,” said Joshua Bolten, president & CEO of Business Roundtable. “And the business community has an important role to play in sharing with employees and the broader communities where they operate the importance of vaccination to help defeat the pandemic and lead our country toward a robust economic recovery.”

On its website, healthaction.org, HAA provides free best-in-class tools, resources, training and events for the business community to help companies deliver trusted, fact-based health communications to employees and encourage consumers to make informed decisions about COVID-19 vaccines.

“COVID-19 vaccine hesitancy is the largest and most critical communications issue in our nation’s history, and it’s one that can’t be solved without public health and business working together,” said Lisa Sherman, president and CEO of the Ad Council. “We know that Americans are turning to their employers as one of the most trusted sources of information and action around the COVID crisis—and that the corporate community has a significant role to play in helping us shift from vaccine hesitancy to vaccine confidence.”…

To access these resources and learn more about how businesses can participate, visit www.healthaction.org

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout

 COVAX – Ghana, Cote Ivoire

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout
Press release 02/24/2021
:: COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week
:: Final first round of allocations for doses of AstraZeneca/Oxford and Pfizer-BioNTech vaccines, to the majority of countries and economies participating in the COVAX Facility, anticipated to be published in the coming days
:: Beginning of global rollout means that, as readiness criteria are met and doses produced, vaccines will be shipped to Facility participants on a rolling basis

GENEVA/NEW YORK/OSLO, 24 February 2021 – Today, Ghana became the first country outside India to receive COVID-19 vaccine doses shipped via the COVAX Facility. This is a historic step towards our goal to ensure equitable distribution of COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals that will continue in the coming days and weeks.

On 23 February, COVAX shipped 600,000 doses of the AstraZeneca/ Oxford vaccine, from the Serum Institute of India (SII) from Pune, India to Accra, Ghana, arriving on the morning of 24 February.  The arrival in Accra is the first batch shipped and delivered in Africa by the COVAX Facility as part of an unprecedented effort to deliver at least 2 billion doses of COVID-19 vaccines by the end of 2021…

Coronavirus (COVID-19) Vaccinations :: Share of population full vaccinated…

Our World in Data
Coronavirus (COVID-19) Vaccinations
Our World in Data and the SDG-Tracker are collaborative efforts between researchers at the University of Oxford, who are the scientific editors of the website content; and the non-profit organization Global Change Data Lab, who publishes and maintains the website and the data tools that make our work possible. At the University of Oxford we are based at the Oxford Martin Programme on Global Development.

This image has an empty alt attribute; its file name is screen-shot-2021-02-28-at-5.50.04-pm.png

Research and data: Hannah Ritchie, Esteban Ortiz-Ospina, Diana Beltekian, Edouard Mathieu, Joe Hasell, Bobbie Macdonald, Charlie Giattino, and Max Roser
Web development: Breck Yunits, Ernst van Woerden, Daniel Gavrilov, Matthieu Bergel, Shahid Ahmad, Jason Crawford, and Marcel Gerber

 

POLIO Public Health Emergency of International Concern (PHEIC); WHO/OCHA Emergencies

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 24 February 2021
:: As we head towards International Women’s Day (marked on 8 March), GPEI honours two women who left a mark in polio eradication and in women’s empowerment within the U.N.
:: On 15 February, polio eradication Gender Champion Arancha González Laya, Minister for Foreign Affairs, European Union and Cooperation of Spain, visited the Notre Dame des Apôtres hospital in N’Djamena, Chad where she administered polio drops to two newborn children. Read more
“”In a special interview, PolioNews (PN) talks to Holger Knaack (HK), President of Rotary International, about why it is more important than ever to support PolioPlus, Rotary’s polio eradication program, and what lessons it can offer to the global pandemic response.

Summary of new WPV and cVDPV viruses this week (AFP cases and ES positives):
:: Afghanistan: six cVDPV2 cases
:: Pakistan: one WPV1 and two cVDPV2 cases, six WPV1 and five cVDPV2 positive environmental samples
:: Congo: one cVDPV2 case and one cVDPV2 positive environmental sample
:: Egypt: one cVDPV2 positive environmental sample
:: Ethiopia: one cVDPV2 case
:: Guinea: six cVDPV2 cases
:: Mali: two cVDPV2 cases

::::::
::::::

WHO/OCHA Emergencies

Editor’s Note:
Continuing with this edition, we include information about the last apparent update evident on the WHO emergency country webpages, recognizing almost universal and significant interims since last update regardless of the level of the emergency listed.

WHO Grade 3 Emergencies [to 27 Feb 2021]

Democratic Republic of the Congo – No new digest announcements [Last apparent update: 12 Jan 2021]
Mozambique floods – No new digest announcements identified [Last apparent update: 3 November 2020]
Nigeria – No new digest announcements identified [Last apparent update: 29 Jun 2020]
Somalia – No new digest announcements identified [Last apparent update: 17 July 2020]
South Sudan – No new digest announcements identified [Last apparent update: 4 February 2020]
Syrian Arab Republic – No new digest announcements identified [Last apparent update: 24 October 2020]
Yemen – No new digest announcements identified [Last apparent update: 30 June 2020]

::::::

WHO Grade 2 Emergencies [to 27 Feb 2021]
Afghanistan – No new digest announcements identified [Last apparent update: 5 July 2020]
Angola – No new digest announcements identified [Last apparent update: 03 December 2020]
Burkina Faso – No new digest announcements identified [Last apparent update 04 février 2021]
Burundi – No new digest announcements identified [Last apparent update: 04 July 2019]
Cameroon – No new digest announcements identified [Last apparent update: 22 August 2019]
Central African Republic – No new digest announcements identified [Last apparent update: 12 June 2018]
Ethiopia – No new digest announcements identified [Last apparent update: 22 August 2019]
Iran floods 2019 – No new digest announcements identified [Last apparent update: 2 March 2020]
Iraq – No new digest announcements identified [Last apparent update: 21 February 2020]
Libya – No new digest announcements identified [Last apparent update: 7 October 2019]
Malawi Floods – No new digest announcements identified [Last apparent update: 09 October 2019]
Measles in Europe – No new digest announcements identified [Last apparent update: 16-12-2020]
MERS-CoV – No new digest announcements identified [Last apparent update: 8 July 2019]
Mozambique – No new digest announcements identified [Last apparent update: 03 November 2020]
Myanmar No new digest announcements identified [Last apparent update: :: 3 January 2021
Niger – No new digest announcements identified [Last apparent update: 11 février 2021]
occupied Palestinian territory – No new digest announcements identified [Last apparent update: 4 September 2019]
HIV in Pakistan – No new digest announcements identified [Last apparent update: 27 August 2019]
Sao Tome and Principe Necrotizing Cellulitis (2017) – No new digest announcements
Sudan – No new digest announcements identified [Last apparent update: 24 June 2020]
Ukraine – No new digest announcements identified [Last apparent update: 1 May 2019]
Zimbabwe – No new digest announcements identified [Last apparent update: 10 May 2019]

::::::

WHO Grade 1 Emergencies [to 27 Feb 2021]

Chad – No new digest announcements identified [Last apparent update: 30 June 2018]
Djibouti – No new digest announcements identified [Last apparent update: 25 novembre 2020]
Kenya – No new digest announcements identified [Last apparent update: 11 December 2020]
Mali – No new digest announcements identified [Last apparent update: 3 May 2017]
Namibia – viral hepatitis – No new digest announcements identified [Last apparent update: 20 July 2018]
Tanzania – No new digest announcements identified [Last apparent update: 21 October 2020]

::::::
::::::

UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Yemen
::  Yemen: COVID-19 Preparedness and Response Monthly Report (January 2021)
23 February 2021

Syrian Arab Republic – No new digest announcements identified

::::::

UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
East Africa Locust Infestation
:: Desert Locust situation update 23 February 2021

COVID-19
:: Global Humanitarian Response Plan COVID-19 Progress Report: Final Progress Report, 22 February 2021
[See Week in Review above for detail]

::::::
::::::